Skip to main content
NIH

Jeffrey P. Struewing, M.D.

Jeff Struewing
Program Director
Genotype-Tissue Expression Project (GTEx)

Division of Genomic Medicine


M.D. Indiana University, 1985
M.S. University of Maryland, 1988

T: (301) 480-3435
F: (301) 480-2770
E: struewij@mail.nih.gov
Building 6700B, Room 3152
6700B ROCKLEDGE DR, MSC 6908
BETHESDA, MD 20892-6908


Genotype-Tissue Expression Project


Dr. Struewing is a Program Director in the Division of Genomic Medicine at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).

Dr. Struewing joined the NIH in 1991, following three years as a U.S. Navy Medical Officer in San Diego. His interdisciplinary studies initially focused on inherited factors in cancer, particularly breast and ovarian cancer, first in the Genetic Epidemiology Branch and then in the Laboratory of Population Genetics at the National Cancer Institute (NCI), where he received tenure in 2001.

In 2007, Dr. Struewing joined the Office of Population Genomics at NHGRI and is currently in the Division of Genomic Medicine, where he serves as a Program Director. He was involved in launching the Electronic Medical Records and Genomics (eMERGE) project and was co-coordinator of the Genotype-Tissue Expression Project of the NIH Common Fund. He currently works primarily on the Human Health and Heredity in Africa (H3Africa) and Implementing Genomics in Practice (IGNITE-II) projects.

Dr. Struewing received his M.D. in 1985 from Indiana University School of Medicine and his M.S. in Preventive Medicine in 1988 from the University of Maryland School of Medicine, where he also completed his residency. He is Board Certified in Public Health and General Preventive Medicine.

Last Updated: February 15, 2019